Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays.
Animals
Antibodies, Neutralizing
/ immunology
Antibodies, Viral
/ immunology
COVID-19
/ diagnosis
Chlorocebus aethiops
Coronavirus Nucleocapsid Proteins
/ immunology
Humans
Immunoglobulin G
/ immunology
Kinetics
Neutralization Tests
Phosphoproteins
/ immunology
SARS-CoV-2
/ genetics
Severity of Illness Index
Spike Glycoprotein, Coronavirus
/ immunology
Vero Cells
SARS-CoV-2
immunity
neutralizing antibodies
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
26 05 2021
26 05 2021
Historique:
received:
26
04
2021
revised:
21
05
2021
accepted:
24
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
11
6
2021
Statut:
epublish
Résumé
Increasing evidence suggests that some newly emerged SARS-CoV-2 variants of concern (VoCs) resist neutralization by antibodies elicited by the early-pandemic wild-type virus. We applied neutralization tests to paired recoveree sera (
Identifiants
pubmed: 34073577
pii: v13060996
doi: 10.3390/v13060996
pmc: PMC8229637
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Coronavirus Nucleocapsid Proteins
0
Immunoglobulin G
0
Phosphoproteins
0
Spike Glycoprotein, Coronavirus
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Horizon 2020
ID : VEO 874735
Organisme : Jane ja Aatos Erkon Säätiö
Organisme : Helsingin ja Uudenmaan Sairaanhoitopiiri
ID : TYH2018322
Organisme : Academy of Finland
Références
J Immunol. 2020 Aug 15;205(4):915-922
pubmed: 32591393
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Clin Transl Immunology. 2020 Oct 07;9(10):e1189
pubmed: 33072323
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Pathogens. 2021 Feb 02;10(2):
pubmed: 33540924
Emerg Microbes Infect. 2020 Dec;9(1):680-686
pubmed: 32207377
Cell Rep. 2021 Mar 23;34(12):108890
pubmed: 33713594
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Vaccines (Basel). 2020 Jul 15;8(3):
pubmed: 32679691
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Sci Rep. 2021 Feb 10;11(1):3455
pubmed: 33568776
Clin Infect Dis. 2021 Apr 14;:
pubmed: 33851216
Am J Transl Res. 2021 Mar 15;13(3):1197-1208
pubmed: 33841649
Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Viruses. 2021 Jan 20;13(2):
pubmed: 33498157
Cell. 2021 Apr 29;184(9):2384-2393.e12
pubmed: 33794143
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Cell. 2021 Apr 29;184(9):2362-2371.e9
pubmed: 33735608
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Cell. 2021 Mar 4;184(5):1127-1132
pubmed: 33581746
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6
pubmed: 33592168
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
Euro Surveill. 2020 Jul;25(28):
pubmed: 32700670
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622975
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Euro Surveill. 2020 Mar;25(11):
pubmed: 32209163
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
Vaccines (Basel). 2020 Dec 28;9(1):
pubmed: 33379160
mBio. 2021 May 18;12(3):
pubmed: 34006662
Viruses. 2020 May 06;12(5):
pubmed: 32384820
Nature. 2021 May;593(7857):130-135
pubmed: 33684923